With over 6.69 million Stellantis N.V (STLA) shares trading Monday and a closing price of $21.98 on the day, the dollar volume was approximately $146.96 million. The shares have shown a positive half year performance of 39.56% and its price on 12/04/23 lost nearly -0.14%. Currently, there are 3.14B common shares owned by the public and among those 2.15B shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 24 analysts who have offered their price forecasts for STLA have a consensus price objective of $25.56. The analysts have set the share’s price value over the next 12 months at a high of $40.04 and a low of $19.66. The average price target is 13.53% above its recent price level and a downside to the estimated low will see the stock lose -11.8% over that period. But an upside of 45.1% will see the stock hit the forecast high price target while median target price for the stock is $25.24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 70 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 22 of these insider trades were purchases, accounting for 2,237,534 shares. Insider sales of the common stock occurred on 48 occasions, with total insider shares sold totaling 1,285,109 shares.
The top 3 mutual fund holders in Stellantis N.V are Government Pension Fund – Global, Dodge & Cox International Stock F, and Vanguard Total International Stoc. Government Pension Fund – Global owns 32.36 million shares of the company’s stock, all valued at over $602.03 million. The company sold -3.51 million shares recently to bring their total holdings to about 1.03% of the shares outstanding. Vanguard Total International Stoc bought 0.24 million shares to bring its total holdings to over 29.53 million shares at a value of $549.31 million. Vanguard Total International Stoc now owns shares totaling to 0.94% of the shares outstanding.
Shares of Stellantis N.V (NYSE: STLA) opened at $21.78, down -$0.23 from a prior closing price of $22.01. However, the script later moved the day high at 22.08, down -0.14%. The company’s stock has a 5-day price change of 7.64% and 20.37% over the past three months. STLA shares are trading 54.79% year to date (YTD), with the 12-month market performance up to 39.82% higher. It has a 12-month low price of $13.71 and touched a high of $22.02 over the same period. STLA has an average intraday trading volume of 7.06 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.53%, 12.31%, and 21.12% respectively.
Institutional ownership of Stellantis N.V (NYSE: STLA) shares accounts for 28.37% of the company’s 3.14B shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $68.13B and a beta (3y monthly) value of 1.58. The stock’s trailing 12-month PE ratio is 3.34, while the earnings-per-share (ttm) stands at $6.58. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.45% over the week and 1.57% over the month.
Analysts forecast that Stellantis N.V (STLA) will achieve an EPS of $Stellantis N.V. for the current quarter, $21.98 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Intellia Therapeutics, Inc. while analysts give the company a high EPS estimate of $Steel Dynamics, Inc.. Comparatively, EPS for the current quarter was $STAAR Surgical Company a year ago. Earnings per share for the fiscal year are expected to increase by 9.29%, and -8.48% over the next financial year. EPS should shrink at an annualized rate of -6.51% over the next five years, compared to 17.01% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 24 brokerage firm advisors rate Stellantis N.V (STLA) as a “Strong Buy” at a consensus score of 1.29. Specifically, 19 Wall Street analysts polled rate the stock as a buy, while 2 of the 24 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the STLA, a number of firms have released research notes about the stock. Bernstein stated their Outperform rating for the stock in a research note on November 01, 2023, with the firm’s price target at $18.50-$26.40.
